|
Revision of the dermatophyte taxonomy |
DermatoTax |
January 1, 2016 |
December 31, 2019 |
Mycology and aerobiology |
dermatophytes, taxonomy, phylogeny, medical mycology, tinea |
|
Problematic drug use and infectious diseases in Brussels (Belgium) |
Push |
January 1, 2019 |
December 31, 2019 |
Health information |
licit and illicit drugs, injecting drug use, monitoring drugs, patterns of use, hepatitis C virus (HCV) |
|
National Reference Centre for Measles, Mumps and Rubella virus: working to eliminate measles and rubella in Belgium |
NRC MMR |
October 1, 2015 |
December 31, 2019 |
Viral diseases, Epidemiology of infectious diseases |
measles, mumps, rubella, diagnosis, surveillance, oral fluid |
|
Health Examination Survey |
HES |
January 1, 2017 |
December 31, 2019 |
Health information |
health examination, survey, clinical measurement, laboratory analysis, representative sample |
|
Intradermal rabies vaccination trials in humans: towards shorter and cheaper rabies vaccination |
Intradermo |
January 1, 2011 |
December 31, 2019 |
Viral diseases |
rabies, intradermal vaccination, clinical trials |
|
Development of a new generation of anti-tuberculosis vaccines for preventive and therapeutic approaches |
TB-LAV/LV-VAC |
January 1, 2018 |
December 31, 2019 |
Infectious diseases in humans |
tuberculosis, vaccine, lentiviral vector |
|
Development of biomarkers for endocrine disruptors |
EDC BIRTHCOHORT |
April 1, 2015 |
December 31, 2019 |
Risk and health impact assessment |
endocrine disruptor, exposure, placenta, birth cohort (mother-child cohort) |
|
Development of a new, ultra-fast diagnostic platform for the identification and drug-susceptibility testing of Mycobacterium tuberculosis |
TIDRACE |
May 1, 2015 |
December 31, 2019 |
Bacterial diseases |
drug resistance, mycobacterium tuberculosis, diagnostics |
|
National Reference Centre for Human Papillomavirus: monitoring the impact of vaccination on papillomavirus-induced cancers |
NRC HPV |
January 1, 2016 |
December 31, 2019 |
Viral diseases, Cancer centre |
Human papillomavirus, diagnosis, surveillance, cancer, cervix |
|
Hepatitis E virus epidemiology: follow up of an emerging food-borne zoonosis in Belgium |
HEV EPI |
January 1, 2015 |
December 31, 2019 |
Viral diseases, Epidemiology of infectious diseases |
hepatitis E virus, epidemiology, surveillance, emergence, zoonosis |
|
Development of new molecular methods for the quantification of airborne pollen in the context of aerobiological surveillance |
Allerpol |
January 1, 2016 |
December 31, 2019 |
Mycology and aerobiology , Transversal activities in applied genomics |
pollen, molecular biology, Real Time PCR, digital PCR |
|
Zoonoses Anticipation and Preparedness Initiative |
ZAPI |
March 1, 2015 |
February 29, 2020 |
Quality of vaccines and blood products |
zoonosis, vaccine |
|
Study of the lead and cadmium contamination in big game meat |
LECAHUNT |
October 1, 2018 |
March 31, 2020 |
Trace elements and nanomaterials |
lead, cadmium, trace elements, heavy metals, game meat, hunting |
|
Diagnosis, monitoring and prevention of exposure-related non-communicable diseases |
DiMoPEx |
April 11, 2016 |
April 10, 2020 |
Risk and health impact assessment |
environmental determinants, chronic diseases, network, Horizon 2020 programme |
|
The presence of Chlamydia trachomatis among the population in Belgium |
CTstudy |
May 1, 2019 |
May 1, 2020 |
Epidemiologie van infectieziekten |
|
|
Monitoring of possible health effects of living in the vicinity of nuclear sites in Belgium: childhood leukemia incidence |
NUCABEL 2B |
January 9, 2017 |
June 30, 2020 |
Risk and health impact assessment |
|
|
Acrylamide in other food |
Acrofood |
October 9, 2019 |
June 30, 2020 |
|
acrylamide, food analysis, exposure, risk assesment |
|
Monitoring of possible health effects of living in the vicinity of nuclear sites in Belgium: thyroid cancer incidence |
NUCABEL 2A |
January 9, 2017 |
June 30, 2020 |
Risk and health impact assessment |
nuclear sites, incidence, childhood leukemia, thyroid cancer |
|
Bringing a Health Claim to Information: “ Measuring the impact of health data on the health outcomes of European citizens” |
BAHCI |
August 1, 2018 |
July 31, 2020 |
Epidemiology and public health |
health information systems, knowledge translation, evidence informed decision-making, evidence-based policy, health system performance, European public health research |
|
Feasibility of a population-based cohort in Belgium: development of a business case and roadmap |
Belcohort |
August 6, 2018 |
July 31, 2020 |
Health information |
population-based cohort, chronic diseases, ageing, lifestyle, health policy, research infrastructure |
|
Assessing spatio-temporal relationships between respiratory health and biodiversity using individual wearable technology |
RespirIT |
December 15, 2015 |
September 15, 2020 |
Mycology and aerobiology , Risk and health impact assessment |
allergy, pollen, mobile health, ecohealth, rhinitis, respiratory health, GPS tracking, citizen science, biodiversity |
|
Physico-chemical characterisation and exposure analysis of nanoparticles in food additives in the context of risk assessment |
EFSA-Nano |
October 1, 2018 |
September 30, 2020 |
Trace elements and nanomaterials, Risk and health impact assessment |
E171, E174, E175, food matrix, image analysis, representative test material, nanoparticles, electron diffraction, energy dispersive X-ray spectroscopy, quantitative electron microscopy, transmission electron microscopy, scanning electron microscopy, high angle annular dark field, scanning transmission electron microscopy, (single particle)-inductively coupled plasma mass spectrometry, risk analysis, exposure assessment, market study |
|
The incidence of citrinin in the Belgian food and feed chain and the risk for human and animal health |
CITRIRISK |
October 1, 2016 |
September 30, 2020 |
Organic contaminants and additives |
Mycotoxin, Citrinin, occurrence, food safety, feed, Belgium, toxicokinetics, broiler chickens, pig, biotransformation |
|
Characterisation and risk evaluation of counterfeit antibiotics on the European market |
counterfeit antibiotics |
October 1, 2016 |
October 1, 2020 |
Medicines and health products |
counterfeit antibiotics, quality control, impurities, market study |
|
DNA-debate |
DNA-debate |
February 1, 2018 |
November 1, 2020 |
Kankercentrum |
|
|
National Reference Laboratory for Mycotoxins, Plant Toxins and Marine Biotoxins |
NRL Toxines |
January 1, 2017 |
December 31, 2020 |
Organic contaminants and additives |
national reference laboratory, toxins, mycotoxins, marine toxins, plant toxins |
|
National Reference Laboratory for Genetically Modified Organisms |
NRL-GMO |
January 1, 2006 |
December 31, 2020 |
Transversal activities in applied genomics |
GMO, NRL, food safety |
|
Monitoring the performance of detection methods for SARS-CoV-2 in clinical samples using sequencing data |
COVIPRIM |
April 1, 2020 |
December 31, 2020 |
Viral diseases, Quality of laboratories , Transversal activities in applied genomics |
|
|
Development of a next-generation dual-target rabies/flavivirus plasmid-launched live-attenuated vaccine |
Rabyd-Vax |
January 1, 2017 |
December 31, 2020 |
Viral diseases, Immune response |
rabies, yellow fever, vaccine, plasmid, vector |
|
Personalized Medicine: introduction of Next-Generation-Sequencing in Routine diagnostics in (hemato) oncology in Belgium |
canc-NGS |
April 1, 2015 |
December 31, 2020 |
Cancer centre , Quality of laboratories , Platform Healthdata.be |
cancer, genomics, precision medicines, informed consent, health research information |
